Cancer Stem Cell for Tumor Therapy

Area of Science:

• Oncology
• Cancer Stem Cell Biology
• Therapeutic Strategies

Background:

• Tumors present a significant health challenge, with conventional treatments like chemotherapy and radiotherapy often yielding unsatisfactory results.
• Cancer stem cells (CSCs) are increasingly recognized for their pivotal roles in tumor initiation, progression, metastasis, and recurrence.
• Targeted therapies offer enhanced specificity and efficiency compared to traditional cancer treatments.

Purpose of the Study:

• To provide a comprehensive overview of the biological characteristics of cancer stem cells (CSCs).
• To summarize and evaluate various strategies for targeting CSCs.
• To highlight the potential of immunotherapy and combination therapies for anti-CSC treatments.

Main Methods:

• Review of existing literature on cancer stem cell biology.
• Analysis of CSC characteristics including mitotic patterns, metabolic phenotypes, and therapeutic resistance mechanisms.
• Compilation of CSC-targeted strategies, encompassing surface markers, signaling pathways, niches, metabolic pathways, differentiation therapy, and immunotherapy.

Main Results:

• CSCs exhibit distinct biological features, including specific mitotic patterns, metabolic phenotypes, and inherent therapeutic resistance.
• A wide array of CSC-targeting strategies are available, including targeting surface markers, signaling pathways, niches, and metabolic vulnerabilities.
• Immunotherapy, including tumor vaccines, CAR-T cells, oncolytic viruses, and immune checkpoint inhibitors, shows significant potential, especially in combination with other anti-CSC approaches.

Conclusions:

• Targeting cancer stem cells is a viable approach to inhibit tumor progression and improve patient prognosis.
• A diverse range of therapeutic strategies exist for targeting CSCs, offering multiple avenues for intervention.
• Combination therapies, particularly those involving immunotherapy, hold great promise for overcoming CSC-mediated tumor resistance and enhancing treatment efficacy.